about
Carboxyhemoglobin levels in patients with cocaine-related chest pain.Cocaine absorption after application of a viscous cocaine-containing TAC solution.Acute cardiac ischemia in patients with cocaine-associated complaints: results of a multicenter trial.Exception from informed consent: viewpoint of institutional review boards--balancing risks to subjects, community consultation, and future directions.Variability in institutional approaches to ethics review of community-based research conducted in collaboration with unaffiliated organizations.Efficacy of topical anesthesia in children.Nitroglycerin in the treatment of cocaine associated chest pain--clinical safety and efficacy.Potential diversion rates associated with prehospital acute myocardial infarction triage strategies.A public health approach to emergency medicine: preparing for the twenty-first century.Sample size & selection criteria.Participation of women in clinical trials of drug therapies: a context for the controversies.Lorazepam for the Prevention of Recurrent Seizures Related to AlcoholThe lack of efficacy of phenytoin in the prevention of recurrent alcohol-related seizuresEvaluating Acceptance and Understanding of Risk in the Emergency Department:Are All Risk Statements Created Equally?Clinical Characteristics as Predictors of Recurrent Alcohol-related SeizuresUse of the Acute Cardiac Ischemia Time-Insensitive Predictive Instrument (ACI-TIPI) To Assist with Triage of Patients with Chest Pain or Other Symptoms Suggestive of Acute Cardiac Ischemia: A Multicenter, Controlled Clinical TrialSerious poisonings among older adults: a study of hospitalization and mortality rates in Massachusetts 1983-85Pharmacokinetics of epsilon-aminocaproic acid during peritoneal dialysisReversible adsorption (desorption) of aspirin from activated charcoal
P50
Q23921748-2E401B92-34FB-4210-A7B3-C5D522FB5117Q30637320-3697F77A-1F0A-40A7-80A1-0577AD5B3137Q31508845-E44BFA48-E92B-4899-A957-09B98D4B2BB8Q36303589-590E27D3-F73A-43AC-915C-3480E6A112F1Q37454977-24FBAC8C-A89C-49B9-ACD6-D60D89BDAF64Q39421196-05B775B0-90E2-420E-9703-63C7D6C21130Q39488428-BB2E9F0C-4152-491A-B46F-8FEF8D0E93CDQ39698252-16CFC1BF-FB3D-45E8-8B59-C8FDF054C889Q40451487-CEBBAE0C-D0D0-4E51-8B07-AF592E4B4BA2Q47415791-7E32D0E6-8C6D-498D-96DA-A9BB3BC66867Q53463930-EEDFB729-1551-49FB-AA70-D7864FD814ADQ60690613-E5CE044F-BEA5-41B5-8839-EB02E384131DQ60690615-4147D170-8668-4C47-9E78-65EFCD1311CAQ61387970-390BBFF7-0248-46A3-BC51-690F5CD9A0D7Q61387971-7B25486E-F05C-4618-AF6B-806113A395D9Q61387972-E818CB77-5A10-495F-BF38-7E8E4C178FD0Q61387975-5F38849E-8BF5-4B5B-B414-96FC39404C23Q61387977-8806033A-57BE-4CF2-961A-8575C29C5953Q69264623-C696DBE6-2315-4C2B-95AB-4364FC4561D0
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Susan Fish
@ast
Susan Fish
@en
Susan Fish
@es
Susan Fish
@nl
Susan Fish
@sl
type
label
Susan Fish
@ast
Susan Fish
@en
Susan Fish
@es
Susan Fish
@nl
Susan Fish
@sl
prefLabel
Susan Fish
@ast
Susan Fish
@en
Susan Fish
@es
Susan Fish
@nl
Susan Fish
@sl
P106
P21
P31
P496
0000-0001-6309-0558